New study aims to unravel the mystery of PCOS in women with type 1 diabetes

NCT ID NCT07490964

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study investigates why women with type 1 diabetes (T1D) frequently develop polycystic ovary syndrome (PCOS), a condition of high androgen levels. Researchers will compare five groups of 12 participants each, including women with T1D and PCOS, women with T1D alone, men with T1D, women with PCOS alone, and healthy controls. They will measure insulin sensitivity, body composition, hormone levels, and genetic markers to uncover the underlying mechanisms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this research could reveal why some women with type 1 diabetes develop PCOS, potentially guiding future prevention or treatment strategies.
What could go wrong
This is an observational study that does not test a treatment. It may not lead to direct clinical changes, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POLYCYSTIC OVARY SYNDROME (PCOS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Endocrinology and Clinical Nutrition, Hospital Universitario Ramón y Cajal, Carretera de Colmenar Viejo, Km 9.1, 28034-Madrid (Spain)

    Madrid, Madrid, 28034, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.